昊海生科：累计回购约183万股A股股份

Group 1 - The core business of Haohai Biological Technology is primarily in the pharmaceutical manufacturing sector, accounting for 99.83% of its revenue, while other businesses contribute only 0.17% [1] Group 2 - As of August 15, 2025, Haohai Biological Technology has completed its share repurchase program, acquiring approximately 1.83 million A-shares, which represents 0.79% of the total share capital of about 233 million shares [3] - The highest price for the repurchased shares was 63.58 CNY per share, the lowest was 49.25 CNY per share, and the average repurchase price was 56.7 CNY per share, with a total expenditure of approximately 104 million CNY [3]